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INTRODUCTION: Ameloblastoma is a rare 
locally invasive epithelial odontogenic tumour of 
the jaw which can cause significant and 
debilitating bone destruction. In vitro studies of 
ameloblastoma are sparse in the literature, and 
little is known regarding patterns of ameloblastoma 
cell growth and invasion, as well as relevant gene 
and protein expression. This study aims to (i) use 
plastic-compressed collagen gels as a robust and 
relevant biomimetic to culture ameloblastoma cells 
in a 3D in vitro tissue model [1] and (ii) perform 
histology, immunohistochemistry (IHC) and gene 
expression assays to characterise tissue 
remodelling, cell growth and invasiveness.  
 
METHODS: Collagen type I, isolated from rat 
tails (First Link UK), was used to make hydrated 
gels suitable for seeding cells. Ameloblastoma 
AM-1 cell line [2] and HOS and MG-63 
osteoblast-like cells were added to the gel.  Plastic 
compression was then used to expel the water 
content, rapidly increasing the gel’s mechanical 
strength without compromising cell viability [1]. 
Compressed gels were rolled into spirals to provide 
easy handling and provide a multi-layered 3D 
environment to observe tissue remodelling and cell 
distribution. Gels were incubated at 37°C with 5% 
CO2, in the medium appropriate to the cell line 
(Gibco). 
 
Gels were bathed in either mineralising or normal 
media, for up to 4 weeks in culture, to observe the 
extent of collagen remodelling and differences in 
gene expression at different time points. Each gel 
was halved at the end of its culture period. One 
half was processed for histology and the other used 
for TRIzol-based RNA extraction (Invitrogen) and 
subsequent reverse transcription and qPCR 
(Applied Biosystems). H&E staining was 
performed to histologically assess tissue 
remodelling and cell migration (histology was 
carried out at the Royal London Hospital 
Pathology laboratory). IHC will be performed to 
visualise the expression of bone- and cancer- 
associated proteins. 
 
RESULTS: Expression of bone-associated 
proteins osteonectin and alkaline phosphatase, and 
ameloblastoma-associated proteins bcl-2 and 
MMP-2 will be detected by qPCR.  Antibodies 
against bone-related and cancer-related proteins 
will be used in IHC visualisation. Pending results 
will help to characterise growth patterns across the 
different cell types, media types and culture times. 
Fig. 1: Sample H&E-stained transverse sections of 
collagen gel rolls. These 20 day gels contain HOS 
cells and were cultured in normal (left) or 
mineralising (right) medium, producing different 
patterns of collagen disruption, cell viability and 
cell distribution. 
DISCUSSION & CONCLUSIONS: Compressed 
collagen gel is an appropriate tissue model for 
research into ameloblastoma, due to its biological 
relevance; its ultrarapid and reproducible 
construction; tolerance of changing the 
experimental variables; and its support of cell 
viability and migration. Histology of processed 
gels and qPCR of extracted RNA will characterise 
cell growth and migration, collagen remodelling 
and gene expression in AM-1, HOS and MG-63 
cell-seeded collagen gels under different culture 
conditions.  
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